- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
SMAD2 Antibody / Mothers Against Decapentaplegic Homolog 2 Antibody targets SMAD2, a receptor-regulated signaling protein that transmits signals from transforming growth factor-beta (TGF-beta) and activin receptors to the nucleus. SMAD2 belongs to the SMAD family of intracellular signaling mediators and functions alongside SMAD3 in pathways that regulate cell proliferation, differentiation, migration, and tissue homeostasis. Its activity is controlled primarily through phosphorylation by activated type I serine/threonine kinase receptors, allowing extracellular signals to influence transcriptional programs involved in development and cellular responses to environmental changes.
Following ligand binding, TGF-beta or activin receptor complexes activate their associated type I receptors, which phosphorylate SMAD2 at conserved serine residues within its C-terminal SSXS motif. Phosphorylated SMAD2 associates with the common mediator SMAD4, forming complexes that accumulate in the nucleus and regulate gene expression through interactions with DNA-binding transcription factors and transcriptional cofactors. Unlike SMAD3, the predominant full-length SMAD2 isoform contains an insertion within its MH1 domain that limits direct DNA binding. Consequently, SMAD2 relies heavily on interactions with partner proteins to influence transcriptional responses.
SMAD2 contains conserved MH1 and MH2 domains separated by a regulatory linker region. The MH2 domain mediates interactions with receptors, SMAD proteins, and transcriptional regulators, while the linker region contains sites that can be modified by additional signaling pathways. Phosphorylation by MAP kinases and cyclin-dependent kinases can influence SMAD2 stability, localization, and transcriptional activity. These regulatory mechanisms allow TGF-beta signaling to interact with pathways controlling cell cycle progression, cellular stress responses, and differentiation.
SMAD2 signaling contributes to embryonic patterning, mesendoderm specification, epithelial homeostasis, and tissue repair. In cancer, its functions are context dependent. TGF-beta signaling can suppress proliferation during early tumor development, whereas altered pathway regulation may contribute to epithelial-mesenchymal transition, invasion, and metastatic progression in established malignancies. SMAD2 activity is also relevant to fibrotic diseases, where persistent TGF-beta signaling promotes extracellular matrix production and tissue remodeling. Distinguishing total SMAD2 expression from its phosphorylation-dependent activation is important when examining these processes. This SMAD2 Antibody provides a reagent for investigating SMAD2 protein expression and its role in TGF-beta-dependent signaling and transcriptional regulation.
Explore our Signal Transduction Antibodies collection for additional research antibodies targeting proteins involved in TGF-beta signaling, transcriptional regulation, and cellular responses to growth factors.
Optimal dilution of the SMAD2 Antibody / Mothers Against Decapentaplegic Homolog 2 Antibody should be determined by the researcher.
Amino acids E83-Q264 from the human protein were used as the immunogen for the SMAD2 antibody.
Store the SMAD2 antibody at -20oC.
SMAD family member 2 antibody, SMAD homolog 2 antibody, Mothers against decapentaplegic homolog 2 antibody, MAD homolog 2 antibody, SMAD2 protein antibody, SMAD2 signaling protein antibody, TGF-beta receptor-regulated SMAD2 antibody, SMAD2 transcriptional regulator antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.